Why are some of the new anti-Alzheimer’s antibodies better than others? With the FDA’s approval of Lecanemab and Donanemab, it’s worth staying on top of this topic’s latest research.
The 2 newest Alzheimer’s drugs, Leqembi (lecanemab) and Kisunla (donanemab) show promise, but many questions remain. Here are the three next ones.
Right now, there are two FDA approved drugs to treat Alzheimer’s itself. Find out why Remternetug may soon get approval as a third, even better treatment.
Kisunla, the newest Alzheimer’s drug, is rapidly gaining acceptance around the world. Learn what it does and how to get it.
Nature provides some of the best therapies for Alzheimer’s. Daffodils specifically from Wales are a big source of Galanthamine for Alzheimer’s. Rosemary competes head-on with the Alzheimer’s drug donepezil. Learn more about these natural sources.
How do the new drugs Leqembi and Kisunla fight Alzheimer’s? Surprisingly, increases in amyloid-beta protein levels can explain the slowing of Alzheimer’s at least as well as the reduction in amyloid plaques.
Dr. Jason Karlawish from Penn Memory Center discusses the careful process of determining if Lecanemab is right for a patient with Alzheimer’s.
Ely Lilly unveils new $1,000,000,000 facility for drugs including Kisunla for Alzheimer’s. New investment will enhance global medicine production, benefiting millions of patients worldwide
There are no approved treatments for DLB, though it is the second most common type of dementia. Do drugs like donepezil hold the key?
While the initial headlines might seem discouraging, there’s always more to the story. 🌟
A new test that can be completed in less than three minutes enables simple, accurate detection of cognitive impairment and Alzheimer’s in cognitively normal adults, including those with no symptoms of dementia. Find out more.
Scientists say the neurons responsible for transforming experiences into memories are always the first to go in Alzheimer’s. Now they’re taking a closer look to try to figure out why, and what to do about it.
A research study finds when young healthy men had a full, uninterrupted night of rest, their blood levels showed a reduced level of tau, the biomarker for Alzheimer’s disease. The level was higher when they lost just one night of sleep. Learn more.
Researchers found in a study that people who developed dementia were more likely to have their credit rating drop at least two and a half years before the diagnosis. Some had problems managing their money up to six years before. Find out more.
Researchers find that a diet including more fruit, vegetables, beans and tea or coffee lowers the risk of developing dementia later in life. Learn more.
Did you know? Intellectual abilities are increased in the brain by an average 300% in most people ages 60-80.
Too much sleep and too little sleep can contribute to cognitive decline, researchers report. Learn more.
No spam, only news and updates.
